Accueil
Explorer
nav.journalClub
Tendances
Plus
Synapse
⌘+K
Synapse
Langue
Français
Français
Clinical Outcomes Following Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy in the United States: The Endure Study | Synapse
March 3, 2026
View Full Paper
Clinical Outcomes Following Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy in the United States: The Endure Study
MS
Michelle Long Schoettler
Emory University
AM
Andrew Messali
University of Southern California
QA
Qiana Amos
Optum (United States)
See all
Key Points
Clinical outcomes show a significant association with thrombotic microangiopathy, affecting recovery.
The analysis identified 45% of patients experienced vascular complications during the follow-up phase.
This observational analysis utilized a comprehensive dataset from multiple transplant centers across the U.S.
The findings highlight the need for further investigation to optimize management in hematopoietic stem cell transplant recipients.
Demander à l'IA
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Demander à l'IA
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Cite This Study
Copy
Schoettler et al. (Sun,) studied this question.
synapsesocial.com/papers/69a760cec6e9836116a2de54
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.672